Journal: bioRxiv
Article Title: FDA drug repurposing uncovers modulators of dopamine D 2 receptor localization via disruption of the NCS-1 interaction
doi: 10.1101/2025.05.29.656787
Figure Lengend Snippet: (A) Trp emission fluorescence assays. The upper graph displays compounds with affinities below 100 µM, while the lower graph shows those with affinities above 100 µM. (B) Surface plasmon resonance experiments. Binding of the tested compounds at 100 µM over CM4-immobilized NCS-1. Each compound is indicated with a different color code. (C) The binding affinities of the best FDA-selected compounds. Dissociation constants (K d + SD) are indicated. Only compounds with a K d below 100 µM are shown. In parenthesis, the FDA code given for each compound is shown.
Article Snippet: NCS-1 was immobilized on a CM4 sensor chip (Biacore, GE) following a standard amine coupling method.
Techniques: Fluorescence, SPR Assay, Binding Assay